| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2008 | CN101243039A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 08/13/2008 | CN101242875A Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 08/13/2008 | CN101242874A Use of 25-hydroxy vitamin D3 to improve male animal fertility |
| 08/13/2008 | CN101242857A PEG-IFNa and ribavirin for HBV treatment |
| 08/13/2008 | CN101242856A Sustained drug release compositions |
| 08/13/2008 | CN101242850A Composition, function and use of xanthoceras sorbifolia extract and compound isolated from same, method for preparing same |
| 08/13/2008 | CN101242848A Pyrimidine compounds |
| 08/13/2008 | CN101242847A Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators |
| 08/13/2008 | CN101242846A Synergistic modulation of FLT3 kinase using thienopyrimidine and thienopyridine kinase modulators |
| 08/13/2008 | CN101242845A Synergistic modulation of FLT3 kinase using a farnesyl transferase inhibitor |
| 08/13/2008 | CN101242844A Aminopyrimidines as kinase modulators |
| 08/13/2008 | CN101242843A Aminopyrimidines as kinase modulators |
| 08/13/2008 | CN101242842A Use of SANGLIFEHRIN in HCV |
| 08/13/2008 | CN101242841A Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 08/13/2008 | CN101242840A Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 08/13/2008 | CN101242839A Azaindazole compounds and methods of use |
| 08/13/2008 | CN101242838A Synergistic modulation of FLT3 kinase using aminoquinoline and aminoquinazoline kinase modulators |
| 08/13/2008 | CN101242837A Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators and a farnesyl transferase inhibitor |
| 08/13/2008 | CN101242836A Method of improving wakefulness |
| 08/13/2008 | CN101242835A Inhibition of osteolytic lesions by SRC kinase inhibitors |
| 08/13/2008 | CN101242834A Inhibitors of AKT activity |
| 08/13/2008 | CN101242833A Pyrrolopyridine derivatives and use of same as PPAR receptor modulators |
| 08/13/2008 | CN101242832A Fused pyrazole as p38 MAP kinase inhibitors |
| 08/13/2008 | CN101242831A Prophylactic and/or therapeutic method for rheumatoid arthritis |
| 08/13/2008 | CN101242830A Nuclear receptors agonists for treatment of atherosclerosis and/or related cardiovascular disease |
| 08/13/2008 | CN101242829A Pharmaceutical composition comprising PPAR regulator |
| 08/13/2008 | CN101242828A Composition for inhibiting acyl-coA:cholesterol acyltransferase |
| 08/13/2008 | CN101242827A Compositions comprising nebivolol |
| 08/13/2008 | CN101242826A Combination therapy using AZD2171 and platinum anti-tumor agent |
| 08/13/2008 | CN101242825A Use of L-carnitine and/or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 08/13/2008 | CN101242824A Acetylcysteine composition and uses therefor |
| 08/13/2008 | CN101242823A Composition comprising oleic acid and the use thereof |
| 08/13/2008 | CN101242822A 癌症的治疗 The treatment of cancer |
| 08/13/2008 | CN101242821A Novel use of peptide compounds for treating muscle pain |
| 08/13/2008 | CN101242820A Bis(thio-hydrazide amide) formulation |
| 08/13/2008 | CN101242819A Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof |
| 08/13/2008 | CN101242818A Use of a combination comprising L-carnitine or alkanoyl L-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the |
| 08/13/2008 | CN101242817A Use of HIF1 alpha modulators for treatment of cancer |
| 08/13/2008 | CN101242816A HCV inhibitors |
| 08/13/2008 | CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets |
| 08/13/2008 | CN101240275A Nucleic acid molecule SEPTIN1SR2 and application in producing immunity preparation |
| 08/13/2008 | CN101240274A Nucleic acid molecule SEPTIN1SR2 and application in preparing anti-leukemia medicament |
| 08/13/2008 | CN101240273A Nucleic acid molecule SEPTIN1SR1 and application in producing immunity preparation |
| 08/13/2008 | CN101240272A Nucleic acid molecule SEPTIN1SR1 and application in preparing anti-leukemia medicament |
| 08/13/2008 | CN101240271A Toll-like receptor adjustment oligonucleotide and use thereof |
| 08/13/2008 | CN101240037A Jelly fungi heptasaccharide and its preparation technique and application |
| 08/13/2008 | CN101240007A Oleanane triterpene compound with containing multiple unsaturated double bonds and use thereof |
| 08/13/2008 | CN101240006A Oleanane triterpene compound with C ring containing conjugated double bond and use thereof |
| 08/13/2008 | CN101240005A Method for preparing platycodin D from balloon-flower root and application thereof in anti-cancer medicament |
| 08/13/2008 | CN101240002A Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof |
| 08/13/2008 | CN101240001A 2'-fluoro nucleotide |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239990A N-(2,3,4,5,6-pentahydroxyhexyl)-L-amino acid platinum ligand, preparation method and application thereof |
| 08/13/2008 | CN101239989A Nucleotide analog |
| 08/13/2008 | CN101239985A Method for preparing cefodizime sodium |
| 08/13/2008 | CN101239981A Pyrazolo and imidazo-pyrimidine derivatives |
| 08/13/2008 | CN101239980A Immunity receptor regulator couplet precursor, couplet and application thereof |
| 08/13/2008 | CN101239979A Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof |
| 08/13/2008 | CN101239978A Imidazopyridines compounds |
| 08/13/2008 | CN101239972A Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 08/13/2008 | CN101239971A Biphenyl derivatives |
| 08/13/2008 | CN101239970A Biphenyl derivatives |
| 08/13/2008 | CN101239969A Biphenyl derivatives |
| 08/13/2008 | CN101239968A Biphenyl derivatives |
| 08/13/2008 | CN101239964A 15-oxospiramilactone and its medicament composition, preparation method and application |
| 08/13/2008 | CN101239959A Benzopyrone derivative, preparation method and medical use thereof |
| 08/13/2008 | CN101239958A Arylthioureas compounds with antivirus activity, preparation method and use thereof |
| 08/13/2008 | CN101239953A Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans |
| 08/13/2008 | CN101239950A 1-(substituted benzoyl)-indazole-3-carboxylate or amides compounds thereof, synthesis and application thereof |
| 08/13/2008 | CN101239945A Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 08/13/2008 | CN101239936A Antineoplastic sulfur-containing alkannin and naphthoquinones derivatives |
| 08/13/2008 | CN101239929A Trichostatin A derivatives, preparation method and use thereof |
| 08/13/2008 | CN101239928A Propanoic derivatives for treating lipid metabolism disorder |
| 08/13/2008 | CN101239925A Method for preparing magnesium aspartate |
| 08/13/2008 | CN101239918A Beta-elemene diamine derivatives, synthesis method and use thereof |
| 08/13/2008 | CN101239915A Beta-elemene monosubstituted amine derivatives, synthetic method and use thereof |
| 08/13/2008 | CN101239901A Method for preparing ibuprofen arginine salt |
| 08/13/2008 | CN101239711A Method for preparing gene transmission vector nano calcium phosphate |
| 08/13/2008 | CN101239190A Vitamin receptor binding drug delivery conjugates |
| 08/13/2008 | CN101239189A Tenofovir, adefovir and intelligent polymer conjugates and preparation and use thereof |
| 08/13/2008 | CN101239188A Method for improving chemical stability of biological collagen to antibiotic medicine |
| 08/13/2008 | CN101239187A Functionalization carbon nano-tube for tumor lympha targeted therapeutic carrier |
| 08/13/2008 | CN101239186A Use of soluble lymphotoxin-beta receptors |
| 08/13/2008 | CN101239174A Foot plaster and hand plaster |
| 08/13/2008 | CN101239168A Composition with ease pain anti-inflammatory action |
| 08/13/2008 | CN101239163A Medicaments for resisting microwave radiation |
| 08/13/2008 | CN101239151A Chinese medicine and method for preventing and controlling cardiovascular and cerebrovascular diseases |
| 08/13/2008 | CN101239133A Externally-applied plaster for treating protrusion of lumbar intervertebral disc |
| 08/13/2008 | CN101239132A Strong bone-setting medicament for treating bone fracture and traumatic injury |
| 08/13/2008 | CN101239131A Blood-stasis-dissipating blood-circulation-promoting fast fracture-setting medicament |
| 08/13/2008 | CN101239109A Externally-applied plaster for eliminating bony spur and preparation technique |
| 08/13/2008 | CN101239105A Chinese medicine for treating tinea pedis |
| 08/13/2008 | CN101239101A Method for extracting low methoxyl pectin from ficus pumila perianth |
| 08/13/2008 | CN101239096A Chinese medicine ointment for treating beriberi and its manufacturing method |
| 08/13/2008 | CN101239094A Active component composition used as adjuvant drug for antitumor and preparation and application thereof |
| 08/13/2008 | CN101239093A Active component in albizia julibrissin with inhibiting angiogenesis function and preparation method and application thereof |
| 08/13/2008 | CN101239092A Kudzuvine flower isoflavonoid extraction, its extracting method, medicinal composition and its use in pharmaceutical |
| 08/13/2008 | CN101239090A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239089A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239088A Medicinal composition containing caffeine |